NAMI
SNDX icon

Nomura Asset Management International’s Syndax Pharmaceuticals SNDX Stock Holding History

Nomura Asset Management International’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.94M Hold
180,000
– – 0.01% 909
2026
Q1 		$4.21M Hold
180,000
– – 0.01% 820
2025
Q4 		$3.78M Buy
+180,000
New +$3.14M 0.01% 849

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Nomura Asset Management International's SNDX Position: Q2 2026 in Review

Nomura Asset Management International held its Syndax Pharmaceuticals (SNDX) position steady in Q2 2026 at 180,000 shares worth $3.94M. The position accounts for 0.01% of the portfolio, ranked #909.

Nomura Asset Management International first reported a position in SNDX in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.21M in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Nomura Asset Management International held 180,000 shares of Syndax Pharmaceuticals worth $3.94M as of Q2 2026.
  • Nomura Asset Management International left its Syndax Pharmaceuticals share count unchanged in Q2 2026.
  • Syndax Pharmaceuticals made up 0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #909 holding.
  • Nomura Asset Management International first reported a position in Syndax Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Nomura Asset Management International's Syndax Pharmaceuticals position peaked at $4.21M in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.